To hear about similar clinical trials, please enter your email below
Trial Title:
The Role of the Vagus Nerve in Tumor-to-Brain Communication in Lung Cancer Patients
NCT ID:
NCT00397124
Condition:
Lung Cancer
Conditions: Official terms:
Lung Neoplasms
Study type:
Interventional
Study phase:
N/A
Overall status:
Unknown status
Study design:
Allocation:
Randomized
Intervention model:
Parallel Assignment
Masking:
None (Open Label)
Intervention:
Intervention type:
Device
Intervention name:
PET/CT imaging
Summary:
the aim of this study is to measure brain metabolism in patients with lung cancer.FDG
uptake in the brain in patients with malignant tumors will be compared to the amount of
tracer activity found in patients who have benign pulmonary process. if differences
between the brain uptake of FDG in the two groups will be found, further assessment will
be performed in order to evaluate if such differences could be attributed and
specifically localized to the brain regions innervated by the vagus
Criteria for eligibility:
Criteria:
Inclusion Criteria:
- patients with SPN referred for routine whole body FDG-PET imaging
- patients with NSCLC and patients with no evidence of lung cancer on further follow
up
Exclusion Criteria:
- patients with a clinical history of vagotomy, abdominal surgery. brain tumor, brain
trauma or CVA. or those with a systemic inflammatory disease
Gender:
All
Minimum age:
35 Years
Maximum age:
70 Years
Healthy volunteers:
No
Locations:
Facility:
Name:
Rambam Medical Center
Address:
City:
Haifa
Country:
Israel
Status:
Recruiting
Contact:
Last name:
Alex Frenkel, Ph.D
Phone:
972-4-8543009
Email:
a_frenkel@rambam.health.gov.il
Start date:
April 2002
Lead sponsor:
Agency:
Rambam Health Care Campus
Agency class:
Other
Source:
Rambam Health Care Campus
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT00397124
